Medicine & Life Sciences
Type 2 Diabetes Mellitus
100%
Metformin
78%
Glucose
74%
Insulin
67%
Hypoglycemic Agents
48%
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
31%
Insulin Resistance
29%
Glucagon-Like Peptide 1
22%
Hyperglycemia
22%
Insulin Secretion
18%
Obesity
17%
Fatty Acids
16%
Therapeutics
16%
Hypoglycemia
15%
Palmitates
15%
Peptides
14%
2,4-thiazolidinedione
13%
Dipeptidyl-Peptidase IV Inhibitors
13%
Rosiglitazone
13%
Dipeptidyl Peptidase 4
12%
Weight Loss
11%
Thiazolidinediones
11%
Gastric Inhibitory Polypeptide
11%
Pharmaceutical Preparations
11%
Peroxisome Proliferator-Activated Receptors
11%
Blood Glucose
11%
Placebos
10%
Glucagon-Like Peptide-1 Receptor
10%
sibutramine
10%
Safety
10%
Sodium-Glucose Transporter 2 Inhibitors
10%
Islets of Langerhans Transplantation
9%
Incretins
9%
Sodium-Glucose Transport Proteins
9%
BTS 67582
9%
Glucagon
9%
Biguanides
8%
lixisenatide
8%
PPAR gamma
8%
Liver
8%
Pioglitazone
8%
glucagon-like peptide 1 (7-36)amide
7%
Leptin
7%
Meals
7%
Symporters
7%
Hormones
7%
Insulin-Secreting Cells
7%
Obese Mice
7%
Skeletal Muscle
7%
Streptozocin
6%
Chemistry
Insulin Derivative
38%
Metformin
21%
Antidiabetic Agent
20%
Insulinotropic
19%
Glucose
18%
Polypeptide
9%
Glucagon-Like Peptide 1
8%
Metabolic
8%
Saturated Fatty Acid
7%
Leptin
7%
Fatty Acid
7%
Glycemic
6%
Plasma
6%
Resistance
5%
Ceramide
5%
Hormone
5%
Peptide
5%